<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03765749</url>
  </required_header>
  <id_info>
    <org_study_id>PMK-032</org_study_id>
    <nct_id>NCT03765749</nct_id>
  </id_info>
  <brief_title>Empirical Antibiotic and Outcome in Community-onset Bacteremia</brief_title>
  <official_title>Empirical Antibiotic and Outcome in Community-onset Bacteremia Caused by Third Generation Cephalosporin Resistant Enterobacteriaceae</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phramongkutklao College of Medicine and Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phramongkutklao College of Medicine and Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Empirical antibiotic and outcome in Community-onset Bacteremia Caused by third generation
      cephalosporin resistant Enterobacteriaceae
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective cohort study is conducted for monitoring outcomes and risk factors among
      community-onset bacteremia caused by third generation cephalosporin resistant
      enterobacteriaceae.

      Primary endpoint is mortality rate among those who received initially inappropriate
      antimicrobial which switch to appropriate antimicrobial later when culture and antimicrobial
      susceptibility test reported among community-onset bacteremia caused by third generation
      cephalosporin resistant enterobacteriaceae.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 22, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality rate among community-onset bacteremia caused by third generation cephalosporin resistant enterobacteriaceae</measure>
    <time_frame>January 2018 - march 2019</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Bacteremia</condition>
  <arm_group>
    <arm_group_label>Community onset 3rd generation cephalosporin resistant entero</arm_group_label>
    <description>Patient with Community onset third generation cephalosporin resistant enterobacteriaceae bacteremia who received inappropriate Antibiotic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nosocomial onset 3rd generation cephalosporin resistant ente</arm_group_label>
    <description>Patient with Nosocomial onset third generation cephalosporin resistant enterobacteriaceae bacteremia who received appropriate Antibiotic</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with community-onset bacteremia caused by third generation cephalosporin resistant
        enterobacteriaceae. Age &gt; 18 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with Community-onset Bacteremia Caused by third generation cephalosporin
             resistant Enterobacteriaceae. Age &gt; 18 years

        Exclusion Criteria:

          -  Pregnancy

          -  Polymicrobial infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Worapong Nasomsong, M.D.</last_name>
    <phone>+66842111220</phone>
    <email>ninenon32@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vasin Vasikasin, M.D.</last_name>
    <phone>+66842111220</phone>
    <email>vvasin@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Worapong Nasomsong</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Worapong Nasomsong</last_name>
      <phone>+66842111220</phone>
      <email>ninenon32@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Vasin Vasikasin</last_name>
      <phone>+66842111220</phone>
      <email>vvasin@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>March 22, 2018</study_first_submitted>
  <study_first_submitted_qc>December 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 5, 2018</study_first_posted>
  <last_update_submitted>December 3, 2018</last_update_submitted>
  <last_update_submitted_qc>December 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Phramongkutklao College of Medicine and Hospital</investigator_affiliation>
    <investigator_full_name>Vasin Vasikasin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacteremia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

